LncRNA CCAT2 promotes malignant progression of metastatic gastric cancer through regulating CD44 alternative splicing.

[1]  Tian Li,et al.  Research progress on the interaction between oxidative stress and platelets: Another avenue for cancer? , 2023, Pharmacological research.

[2]  Yan Wang,et al.  The role of non-coding RNAs (miRNA and lncRNA) in the clinical management of rheumatoid arthritis. , 2022, Pharmacological research.

[3]  M. Hashemi,et al.  Long non-coding RNA (lncRNA) H19 in human cancer: From proliferation and metastasis to therapy. , 2022, Pharmacological research.

[4]  Gang Chen,et al.  LncRNA HEPFAL accelerates ferroptosis in hepatocellular carcinoma by regulating SLC7A11 ubiquitination , 2022, Cell Death & Disease.

[5]  Z. Xiang,et al.  Retard or exacerbate: Role of long non-coding RNA growth arrest-specific 5 in the fibrosis. , 2022, Cytokine & growth factor reviews.

[6]  A. Brown,et al.  Osteopontin/secreted phosphoprotein‐1 harnesses glial‐, immune‐, and neuronal cell ligand‐receptor interactions to sense and regulate acute and chronic neuroinflammation , 2022, Immunological reviews.

[7]  A. Aref,et al.  Crosstalk between lncRNAs in the apoptotic pathway and therapeutic targets in cancer. , 2022, Cytokine & growth factor reviews.

[8]  Yuting Wu,et al.  CD44 deficiency represses neuroinflammation and rescues dopaminergic neurons in a mouse model of Parkinson's disease. , 2022, Pharmacological research.

[9]  Xinsheng Gu,et al.  Identifying Optimal Surgical Intervention-Based Chemotherapy for Gastric Cancer Patients With Liver Metastases , 2021, Frontiers in Oncology.

[10]  Huaxi Xu,et al.  LncRNA Snhg6 regulates the differentiation of MDSCs by regulating the ubiquitination of EZH2 , 2021, Journal of Hematology & Oncology.

[11]  S. Batra,et al.  Pathophysiological role of growth differentiation factor 15 (GDF15) in obesity, cancer, and cachexia. , 2021, Cytokine & growth factor reviews.

[12]  K. Lynch,et al.  The three as: Alternative splicing, alternative polyadenylation and their impact on apoptosis in immune function , 2021, Immunological reviews.

[13]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[14]  Liang Zhao,et al.  LncRNA CRNDE attenuates chemoresistance in gastric cancer via SRSF6-regulated alternative splicing of PICALM , 2021, Molecular Cancer.

[15]  Bo Yang,et al.  miRNA-21 may serve as a promising noninvasive marker of glioma with a high diagnostic performance: a pooled analysis of 997 patients , 2021, Therapeutic advances in medical oncology.

[16]  Kongming Wu,et al.  CD44 as a tumor biomarker and therapeutic target , 2020, Experimental Hematology & Oncology.

[17]  E. Cortesi,et al.  Baseline CD44v6-positive circulating tumor cells to predict first-line treatment failure in patients with metastatic colorectal cancer , 2020, Oncotarget.

[18]  B. Cao,et al.  Role of circular RNAs and long non-coding RNAs in the clinical translation of gastric cancer (Review) , 2020, International journal of molecular medicine.

[19]  Carla Oliveira,et al.  Skipping Exon-v6 from CD44v6-Containing Isoforms Influences Chemotherapy Response and Self-Renewal Capacity of Gastric Cancer Cells , 2020, Cancers.

[20]  Lucas C. Reineke,et al.  The Long Noncoding RNA CCAT2 induces chromosomal instability through BOP1 - AURKB signaling. , 2020, Gastroenterology.

[21]  Ruibing Chen,et al.  Interactome analysis reveals that lncRNA HULC promotes aerobic glycolysis through LDHA and PKM2 , 2020, Nature Communications.

[22]  Junjun Li,et al.  High expression of ESRP1 regulated by circ-0005585 promotes cell colonization in ovarian cancer , 2020, Cancer Cell International.

[23]  H. Seimiya,et al.  c-KIT regulates stability of cancer stemness in CD44-positive colorectal cancer cells. , 2020, Biochemical and biophysical research communications.

[24]  Mei-Yi Tao,et al.  LncRNA CCAT2 promotes angiogenesis in glioma through activation of VEGFA signalling by sponging miR-424 , 2020, Molecular and Cellular Biochemistry.

[25]  P. Granja,et al.  Expression of CD44v6-Containing Isoforms Influences Cisplatin Response in Gastric Cancer Cells , 2020, Cancers.

[26]  J. Ajani,et al.  Non-coding RNAs in GI cancers: from cancer hallmarks to clinical utility , 2020, Gut.

[27]  C. Reis,et al.  Impact of Truncated O-glycans in Gastric-Cancer-Associated CD44v9 Detection , 2020, Cells.

[28]  Jia Liu,et al.  LncRNA LINRIS stabilizes IGF2BP2 and promotes the aerobic glycolysis in colorectal cancer , 2019, Molecular Cancer.

[29]  Su Yao,et al.  Long noncoding RNA GAS5 inhibits progression of colorectal cancer by interacting with and triggering YAP phosphorylation and degradation and is negatively regulated by the m6A reader YTHDF3 , 2019, Molecular Cancer.

[30]  F. Pinaud,et al.  GRP78 regulates CD44v membrane homeostasis and cell spreading in tamoxifen-resistant breast cancer , 2019, Life Science Alliance.

[31]  J. Yu,et al.  ESRP1 Induces Cervical Cancer Cell G1-Phase Arrest Via Regulating Cyclin A2 mRNA Stability , 2019, International journal of molecular sciences.

[32]  Y. Zhang,et al.  Acetylation of PHF5A Modulates Stress Responses and Colorectal Carcinogenesis through Alternative Splicing-Mediated Upregulation of KDM3A. , 2019, Molecular cell.

[33]  Zekuan Xu,et al.  Circular RNA circNRIP1 acts as a microRNA-149-5p sponge to promote gastric cancer progression via the AKT1/mTOR pathway , 2019, Molecular Cancer.

[34]  Lihua Dong,et al.  CD44v6 engages in colorectal cancer progression , 2019, Cell Death & Disease.

[35]  Y. Cho,et al.  ESRP1‐Induced CD44 v3 Is Important for Controlling Pluripotency in Human Pluripotent Stem Cells , 2018, Stem cells.

[36]  Lei Dong,et al.  RETRACTED ARTICLE: LncRNA CASC11 promoted gastric cancer cell proliferation, migration and invasion in vitro by regulating cell cycle pathway , 2018, Cell cycle.

[37]  F. Du,et al.  LncRNA CCAT2 promoted osteosarcoma cell proliferation and invasion , 2018, Journal of cellular and molecular medicine.

[38]  Junjun Li,et al.  Snail Driving Alternative Splicing of CD44 by ESRP1 Enhances Invasion and Migration in Epithelial Ovarian Cancer , 2017, Cellular Physiology and Biochemistry.

[39]  J. Que,et al.  FOXO1: Another avenue for treating digestive malignancy? , 2017, Seminars in cancer biology.

[40]  Yanmei Zhang,et al.  Ring finger protein 43 associates with gastric cancer progression and attenuates the stemness of gastric cancer stem-like cells via the Wnt-β/catenin signaling pathway , 2017, Stem Cell Research & Therapy.

[41]  Y. Zavros.  Initiation and Maintenance of Gastric Cancer: A Focus on CD44 Variant Isoforms and Cancer Stem Cells , 2017, Cellular and molecular gastroenterology and hepatology.

[42]  Gang Li,et al.  A CD44v+ subpopulation of breast cancer stem-like cells with enhanced lung metastasis capacity , 2017, Cell Death & Disease.

[43]  Kecheng Zhang,et al.  Genome-Wide lncRNA Microarray Profiling Identifies Novel Circulating lncRNAs for Detection of Gastric Cancer , 2017, Theranostics.

[44]  S. Choi,et al.  Nomogram Incorporating CD44v6 and Clinicopathological Factors to Predict Lymph Node Metastasis for Early Gastric Cancer , 2016, PloS one.

[45]  S. Hanash,et al.  Allele-Specific Reprogramming of Cancer Metabolism by the Long Non-coding RNA CCAT2. , 2016, Molecular cell.

[46]  Simone Brabletz,et al.  A self‐enforcing CD44s/ZEB1 feedback loop maintains EMT and stemness properties in cancer cells , 2015, International journal of cancer.

[47]  H. Serve,et al.  Ubiquitination and selective autophagy , 2012, Cell Death and Differentiation.

[48]  M. Ohmura,et al.  CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc(-) and thereby promotes tumor growth. , 2011, Cancer cell.

[49]  Claude C. Warzecha,et al.  ESRP1 and ESRP2 are epithelial cell-type-specific regulators of FGFR2 splicing. , 2009, Molecular cell.